Semiquantitative analysis revealed that the reduction in HMGB1 signal efficiency in tumor slices treated with iMWA combined with DA‐COD‐OD‐HCS (group III) was the greatest, at only 18.6%, compared with that in group I (Figure 4E,F). The gene discussed is HMGB1; the disease is neoplasm.